期刊文献+

肾癌外周血循环肿瘤细胞的筛查研究 被引量:4

Screening circulating tumor cells of blood in renal carcinoma
下载PDF
导出
摘要 目的探讨细胞角蛋白(CK)19作为循环肿瘤细胞的间接标志物的价值,以及CK19在肾癌患者外周血中的表达水平以及临床意义。方法选取健康人50名作为对照组,50例肾细胞癌患者作为肾癌组,首先进行对照组和肾癌组间CK19的指标测定,采用流式细胞术检测上述人群外周血中CK19的表达情况;再分析肾癌组内CK19的表达水平与肾癌病理分型、病理分期及组织学分级之间的关系。结果 50名对照组中无一例CK19阳性,50例肾癌组中24例CK19阳性;不同肾癌病理分型之间CK19表达差异无统计学意义(P>0.05),不同肾癌病理分期及组织学分级之间CK19表达差异具有统计学意义(P<0.05)。结论 CK19能够初步判断患者外周血循环肿瘤细胞的水平,对早期无创性诊断肾癌、预测其生物学行为有一定的参考价值,值得进一步探索和研究。 Objective To detect the level of CK19 in peripheral blood in patients with renal cell carcinoma (RCC) and the healthy ,and to evaluate the clinical significance of CK 19 in the peripheral blood among RCC .Meth-ods Fifty healthies and 50 patients of RCC had been chosen .We used lymphocyte separation medium to enrich and then to detect CK19 by flow cytometry between control group and test group .The level of CK19 among test groups and relationship among CK19 and pathological classification ,pathological stage and histological grade were analyzed.Results Zero case of 50 in control group were positive .Twenty-four cases of 50 in test group were posi-tive .The difference of different pathological classification had no statistical meaning (P>0 .05) .The difference of different pathological stage and histological grade had statistical meaning (P<0 .05) .Conclusion By this experi-ment ,it is proved that the level of CK19 in peripheral blood can forecast the prognosis of RCC .To some extent the prognosis of RCC has correlate with CK19 theoretically ,but no statistical meaning is found between the two factors .This method is worthy to be studied.
出处 《山西医药杂志》 CAS 2014年第12期1347-1349,共3页 Shanxi Medical Journal
基金 新疆医科大学科研创新基金(XJC201241)
关键词 肾肿瘤 循环肿瘤细胞 研究 Kidney neoplasms Neoplasm circulating cells Research
  • 相关文献

参考文献4

  • 1Rosamonde E. Banks,Rachel A. Craven,Patricia Harnden,Sanjeev Madaan,Adrian Joyce,Peter J. Selby.Key clinical issues in renal cancer: a challenge for proteomics[J].World Journal of Urology.2007(6)
  • 2Jeong Il Yu,Doo Ho Choi,Won Park,Seung Jae Huh,Eun Yoon Cho,Young Hyuk Lim,Jin Suk Ahn,Jung Hyun Yang,Suk Jin Nam.Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: Matched case–control study[J].The Breast.2010(3)
  • 3Kevin V.S. Tan,Benjamin Namdarian,Anthony J. Costello,Christopher M. Hovens.Potential use of circulating endothelial cells as a biomarker of renal cell carcinoma[J].Urologic Oncology: Seminars and Original Investigations.2011(3)
  • 4邢晓雁,王东民.循环肿瘤细胞富集和鉴定技术在乳腺癌患者中的临床验证[J].科技导报,2012,30(21):56-60. 被引量:2

二级参考文献14

  • 1Gupta G P, Massagu6 J. Cancer metastasis: Building a framework[J]. Cell, 2006, 127(4): 679-695.
  • 2Lianidou E S, Markou A. Circulating tumor cells in breast cancer: Detection systems, molecular characterization, and future challenges [J]. Clinical Chemistry, 2011, 57(9): 1242-1255.
  • 3Zhe X, Cher M L, Bonfil R D. Circulating tumor cells: Finding the needle in the haystack[J]. American Journal of Cancer Research, 2011, 1 (6): 740-751.
  • 4Ring A, Smith I E, Dowsett M. Circulating tumour cells in breast cancer [J]. The Lancet Oncology, 2004, 5(2): 79-88.
  • 5Lurje G, Schiesser S, Hoffmann C, et al. Circulating tumor cells in gastrointestinal malignancies: Current techniques and clinical implications [J]. Journal of Oncology, 2010: 392652, doi:10.1155/2010/ 392652.
  • 6Pavlos M, Michael K. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: Systematic review and meta-analysis[J]. BMC Cancer, 2011, 11(1): 336.
  • 7Stott S L, Hsu C H, Tsukrov D I, et al. Isolation of circulating tumorcells using a microvortex-generating herringbone-chip [J]. PNAS, 2010, 107(43): 18392-18397.
  • 8Sieuwerts A M, Kraan J, Bolt J, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells [J]. Journal of the National Cancer Institute, 2009, 101 (1): 61-66.
  • 9Desitter I, Guerrouahen B S, Benali-Furet N, eta/. A new device for rapid isolation by size and characterization of rare circulating tumor ceils [J]. Anticancer Research, 2011, 31(2): 427-441.
  • 10Weissenstein U, Schumann A, Reif M, et al. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies [J]. BMC Cancer, 2012, 12(1): 206.

共引文献1

同被引文献18

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部